Emtricitabine/Tenofovir Disoproxil Teva

Emtricitabine/Tenofovir Disoproxil Teva is a combination medication used for HIV treatment and prevention. This oral medication is manufactured by Teva UK Limited and is available in the EU.

Emtricitabine/Tenofovir Disoproxil Teva is primarily used in the management of HIV infection. It is often prescribed as part of a combination therapy to help control the virus and reduce the risk of transmission. This medication is also used for pre-exposure prophylaxis (PrEP) in individuals at high risk of HIV infection. The active ingredients, emtricitabine and tenofovir disoproxil phosphate, work together to inhibit the replication of the HIV virus.

Common effects of Emtricitabine/Tenofovir Disoproxil Teva may include headaches, nausea, and diarrhea. Some users may also experience fatigue or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Teva should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature, away from moisture and heat. Regular monitoring of kidney function is recommended during treatment.

Emtricitabine/Tenofovir Disoproxil Teva may interact with other medications, including certain antibiotics, antifungals, and other HIV medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.